Related Experiment Videos
Clozapine: plasma levels and prolactin response.
Psychopharmacology
|January 1, 1981
Summary
Clozapine, an antipsychotic, showed therapeutic effects in schizophrenic patients without significantly increasing prolactin levels, even at substantial doses. This confirms clozapine
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Schizophrenia is a complex mental disorder.
- Antipsychotic medications are the cornerstone of treatment.
- Clozapine is an atypical antipsychotic with a unique efficacy profile.
Purpose of the Study:
- To investigate the relationship between plasma clozapine levels and serum prolactin levels.
- To assess the impact of clozapine on prolactin in patients with schizophrenia.
Main Methods:
- Serial plasma clozapine levels were measured.
- Serum prolactin levels were determined.
- Two patients with schizophrenia receiving clozapine were studied.
Main Results:
- Substantial plasma clozapine levels were observed.
- Marked therapeutic response was noted.
- Prolactin levels were unaffected or minimally elevated 11-12 hours post-dose.
Conclusions:
- Clozapine exhibits unusual pharmacokinetic and pharmacodynamic properties.
- The drug's effect on prolactin is distinct from other antipsychotics.
- Further research into clozapine's unique characteristics is warranted.